Home › Funds › J. Goldman & Co LP › CROX

J. Goldman & Co LP position in CROX

CROCS INC · Consumer Discretionary

J. Goldman & Co LP reported holding 151,200 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$17.7M, representing 0.71% of its reported portfolio and ranking #37 among its reported holdings. J. Goldman & Co LP has disclosed CROX holdings in 8 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)151.20K sh
Reported value held$17.74M
Portfolio Weight0.71%
First reportedQ1 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How J. Goldman & Co LP's CROX position evolved

J. Goldman & Co LP first disclosed a stake in CROX in Q1 2024 at 1,501 shares (US$216K). The position peaked in Q3 2026 at 151,200 shares, worth US$17.7M. Across 8 filings, J. Goldman & Co LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 151,200 shares valued at US$17.7M — an increase of 146,200 shares quarter over quarter.. Notable position changes include a 121% increase in Q3 2024 (shares fell 25% over the following quarter), a 563% increase in Q1 2025 (shares fell 5% over the following quarter), a 2924% increase in Q3 2026 (shares rose 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.50K $215.84K New
Q2 2024 2.86K $416.95K Add
Q3 2024 6.31K $913.32K Add
Q4 2024 4.53K $495.95K Reduce
Q1 2025 30.00K $3.19M Add
Q1 2026 5.00K $415.10K New
Q2 2026 5.00K $603.20K Hold
Q3 2026 151.20K $17.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CROX and 13F data

CROX (CROCS INC) is a Consumer Discretionary company. 28 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Patient Capital Management, LLC (US$85.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CROX

All CROX fund holders →

FAQ

How long has J. Goldman & Co LP held CROX?

J. Goldman & Co LP has disclosed CROX holdings in 8 of the last 11 reported quarters, going back to Q1 2024.

What is J. Goldman & Co LP's current position in CROX?

As of Q3 2026, J. Goldman & Co LP holds 151.20K shares of CROX (CROCS INC), valued at $17.74M, representing 0.71% of its reported portfolio and ranking #37.

Has J. Goldman & Co LP been buying or selling CROX?

In the latest 13F filing (Q3 2026), J. Goldman & Co LP increased its position in CROX. The position peaked in Q3 2026 at 151.20K shares.

Which other funds hold CROX?

Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Patient Capital Management, LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.